Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2025-12-24 @ 12:19 PM
NCT ID:
NCT02371161
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of NHL
* relapse and refractory pts
* age ≥ 65 and ≤75
* ECOG performance status \<2
* FIT patients (Instrumental Activity of Daily Living (IADL)=8, Activity of Daily Living (ADL)=6, Cumulative Illness Rating Scale (CIRS) =0 SCORE=3-4, \<5 SCORE=2 )
* evaluable disease
* no RT since 3 week
* absolute neutrophil count \>= 1500/mm3 and platelets \>= 100.000/106L
* Creatinin \<= 1.5 mg/dL and clearance \>40 ml/min/24 h
* bilirubins \< =2 mg/dL
* forced expiratory volume \>50% - arterial pressure O2 \>70 mmHg
* no other neoplastic disease
* Life expectancy\> 3 months
* signed informed consent
Exclusion Criteria:
* HBV+ - HCV+ - HIV+
* NSC involvement - medullar infiltration \> 20%
* other chemotherapy or radiotherapy
* cardiac disease
* alteration of liver and kidney function
* infections
* demented patient
* no compliance and depressed pts
* Frail and Unfit pts
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
75 Years
Study:
NCT02371161
Study Brief:
Protocol Section:
NCT02371161